<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6830040</article-id>
    <article-id pub-id-type="doi">10.1093/database/baz125</article-id>
    <article-id pub-id-type="publisher-id">baz125</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MIRKB: a myocardial infarction risk knowledge base</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zhan</surname>
          <given-names>Chaoying</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shi</surname>
          <given-names>Manhong</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
        <xref ref-type="aff" rid="aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Rongrong</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>He</surname>
          <given-names>Hongxin</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Xingyun</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shen</surname>
          <given-names>Bairong</given-names>
        </name>
        <!--<email>bairong.shen@scu.edu.cn</email>-->
        <xref ref-type="aff" rid="aff3">3</xref>
        <xref rid="cor1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <aff id="aff1"><label>1</label><institution>Centre for Systems Biology, Soochow University</institution>, Suzhou 215006, <country country="CN">China</country></aff>
    <aff id="aff2"><label>2</label><institution>College of Information and Network Engineering, Anhui Science and Technology University</institution>, Fengyang, Anhui 233100, <country country="CN">China</country></aff>
    <aff id="aff3"><label>3</label><institution>Institutes for Systems Genetics, West China Hospital, Sichuan University</institution>, Chengdu 610041, <country country="CN">China</country></aff>
    <author-notes>
      <corresp id="cor1">Correspondence may also be addressed to Bairong Shen: Phone/Fax: +86-28-85164199; Email: <email>bairong.shen@scu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2019-11-04">
      <day>04</day>
      <month>11</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>04</day>
      <month>11</month>
      <year>2019</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>2019</volume>
    <elocation-id>baz125</elocation-id>
    <history>
      <date date-type="received">
        <day>6</day>
        <month>2</month>
        <year>2019</year>
      </date>
      <date date-type="rev-recd">
        <day>8</day>
        <month>6</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>15</day>
        <month>9</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baz125.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Myocardial infarction (MI) is a common cardiovascular disease and a leading cause of death worldwide. The etiology of MI is complicated and not completely understood. Many risk factors are reported important for the development of MI, including lifestyle factors, environmental factors, psychosocial factors, genetic factors, etc. Identifying individuals with an increased risk of MI is urgent and a major challenge for improving prevention. The MI risk knowledge base (MIRKB) is developed for facilitating MI research and prevention. The goal of MIRKB is to collect risk factors and models related to MI to increase the efficiency of systems biological level understanding of the disease. MIRKB contains 8436 entries collected from 4366 articles in PubMed before 5 July 2019 with 7902 entries for 1847 single factors, 195 entries for 157 combined factors and 339 entries for 174 risk models. The single factors are classified into the following five categories based on their characteristics: molecular factor (2356 entries, 649 factors), imaging (821 entries, 252 factors), physiological factor (1566 entries, 219 factors), clinical factor (2523 entries, 561 factors), environmental factor (46 entries, 26 factors), lifestyle factor (306 entries, 65 factors) and psychosocial factor (284 entries, 75 factors). MIRKB will be helpful to the future systems level unraveling of the complex mechanism of MI genesis and progression.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">National Natural Science Foundation of China</named-content>
          <named-content content-type="funder-identifier">10.13039/501100001809</named-content>
        </funding-source>
        <award-id>31670851</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">National Key Research and Development Program of China</named-content>
          <named-content content-type="funder-identifier">10.13039/501100012166</named-content>
        </funding-source>
        <award-id>2016YFC1306605</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Myocardial infarction (MI) is defined as myocardial necrosis due to coronary ischemia. MI is a common cardiovascular disease and a leading cause of death worldwide. In the USA, someone will develop MI approximately every 40 seconds. It has been estimated that 605 000 Americans will have a new acute MI and another 200 000 will have a recurrent MI event each year (<xref rid="ref1" ref-type="bibr">1)</xref>. Many advanced approaches have been developed for the management of patients with MI, such as thrombolytic therapy and interventional therapy (<xref rid="ref2" ref-type="bibr">2–4)</xref>. However, MI remains a major problem worldwide. The main risk factors for MI include genetic susceptibility and non-genetic factors such as hypertension, obesity, diabetes and lifestyle (<xref rid="ref5" ref-type="bibr">5–10)</xref>. Many studies have shown that smoking is not only a risk factor for the onset of MI but also a predictor of a poor prognosis for MI (<xref rid="ref7" ref-type="bibr">7</xref>, <xref rid="ref11" ref-type="bibr">11</xref>, <xref rid="ref12" ref-type="bibr">12)</xref>. Some other studies demonstrated that smoking is not significantly associated with the onset and prognosis of MI (<xref rid="ref13" ref-type="bibr">13–16)</xref>. It was reported that high physical activity (PA) is a protective factor for 1-year readmission due to non-cardiovascular disease in patients with MI (<xref rid="ref17" ref-type="bibr">17)</xref>. PA is also a protective factor for the incidence of MI (<xref rid="ref18" ref-type="bibr">18)</xref>, although another study indicated that PA is not significantly associated with the risk of acute MI (<xref rid="ref19" ref-type="bibr">19)</xref>. Family history of premature coronary artery disease plays an important role in the development of MI (<xref rid="ref10" ref-type="bibr">10)</xref>. Many studies showed that identifying individuals with an increased risk of MI is a major challenge for enhancing prevention.</p>
    <p>With our increased understanding of the pathogenesis of MI, the applications of biomarkers for early diagnosis, treatment strategies and prognosis evaluation in MI have become very popular in recent researches. Biomarkers are classified as molecular markers, imaging markers and physiological markers according to their properties, and they are also classified as diagnostic markers, therapeutic markers and prognostic markers according to their clinical applications. Clinically, cardiac troponin and creatine kinase-MB can be used as biomarkers for the diagnosis, treatment and prognosis of MI (<xref rid="ref20" ref-type="bibr">20–24)</xref>. The fragmented QRS complex in the electrocardiogram (ECG) is a prognostic marker for in-hospital life-threatening arrhythmic complications in ST-segment elevation MI (STEMI) patients (<xref rid="ref25" ref-type="bibr">25)</xref>. In recent years, microRNAs have been employed not only as biomarkers of MI development, but also as predictors for treatment monitoring and poor prognosis (<xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref27" ref-type="bibr">27)</xref>. It is well known that microRNA-1 (miR-1) plays an important role in heart disease, and studies have shown that miR-1 may be employed as a biomarker for the diagnosis of acute MI (<xref rid="ref28" ref-type="bibr">28</xref>, <xref rid="ref29" ref-type="bibr">29)</xref>. In addition, miR-133 has been used as a marker for the diagnosis of acute non-STEMI (<xref rid="ref30" ref-type="bibr">30)</xref>, and Cortez-Dias <italic>et al.</italic> showed that the miR-122-5p/miR-133b ratio is a predictor of major adverse cardiac events in patients with acute STEMI (<xref rid="ref31" ref-type="bibr">31)</xref>.</p>
    <p>Based our knowledge, no specific database containing risk factors and biomarkers related to MI is available, we therefore constructed here a knowledge base i.e. the MI risk knowledge base (MIRKB) for the understanding and prediction of the MI risk. The goal of MIRKB was to collect risk factors and models related to MI to improve the systems biological level understanding of MI. MIRKB is manually curated and constantly updated by the authors in order to include new data as soon as they are available. MIRKB also allows users to contribute to the project through an online data submission form.</p>
  </sec>
  <sec id="sec2">
    <title>Database description</title>
    <sec id="sec3">
      <title>Data collection and statistics</title>
      <p>Regarding data collection, all the data for our MIRKB were collected from the public database PubMed (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed">www.ncbi.nlm.nih.gov/pubmed</ext-link>) by human text mining. We conducted the search of PubMed using keywords such as ‘MI‘ and ‘biomarker or marker or indicator or predictor or risk factor or risk model‘, etc.</p>
      <p>We set the following criteria for the studies included in our database: (i) epidemiological population studies of MI; (ii) studies associated with the risk, diagnosis, prognosis and treatment of MI; (iii) studies that used one or more statistics to evaluate relationships with MI (e.g. sensitivity, specificity, positive predictive value, negative predictive value, area under the curve of the receiver operating characteristic curve, <italic>P</italic>-value, hazard ratio, odds ratio and risk ratio and their 95% confidence intervals, etc.). Duplicate studies, animal studies, reviews, case reports, letters, studies without full texts, and studies with defective designs and poor quality were then excluded. In addition, we classified the MI patients into young and elderly populations according to the descriptions reported in the researches and the patients younger than 65 years old were classified as young population and the others were grouped to elderly population.</p>
      <p>Based on these criteria, 9577 articles from PubMed have been collected as the original data for our database MIRKB before 5 July 2019. There were still 9485 articles remained after removing the duplicates. Since only the literature related to the risk, diagnosis, prognosis and treatment of MI in human was considered to be collected into our database, we excluded animal articles (<italic>n</italic> = 127), reviews, case reports and letters (<italic>n</italic> = 1433), articles without available data (<italic>n</italic> = 2918), after which 5007 original articles remained. By reading the full text of articles, there were 4366 original articles finally after we removed articles without full text (<italic>n</italic> = 378) and articles without available data (<italic>n</italic> = 263). The detail about the literature collection is shown as a flowchart in <xref rid="f1" ref-type="fig">Figure 1</xref>. The next step was to extract information from the 4366 articles. This step was manually curated to ensure that the associations between risk factors, risk models and MI existed and were significant and that sufficient details were recorded for the associations. If some studies prove that certain risk factors are not significantly associated with MI, other studies have clearly indicated that they have statistical relationships, and these studies remain. Finally, we integrated the collected data, and when a risk factor has multiple names, it is labeled with a uniform official name. For example, brain natriuretic peptide (BNP), also known as B-type natriuretic peptide, was named by using ‘BNP’ according to NCBI protein.</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>The flowchart for the manual collection of MI risk factors and models.</p>
        </caption>
        <graphic xlink:href="baz125f1"/>
      </fig>
      <p>The MIRKB database contains a total of 8436 entries collected from 4366 articles in PubMed with 7902 entries for 1847 single factors, 195 entries for 157 combined factors and 339 entries for 174 risk models. The single factors are classified into the following five categories based on their characteristics: molecular factor (2356 entries, 649 factors), imaging (821 entries, 252 factors), physiological factor (1566 entries, 219 factors), clinical factor (2523 entries, 561 factors), environmental factor (46 entries, 26 factors), lifestyle factor (306 entries, 65 factors) and psychosocial factor (284 entries, 75 factors). There were 572 entries for young population and 217 entries for elderly population based on the research population. According to the applications involved, there were 1755 entries for risk assessment, 279 entries for diagnosis, 6165 entries for prognosis, 112 entries for treatment and 127 entries for others. Descriptive statistics for the database are shown in <xref rid="TB1" ref-type="table">Table 1</xref>.</p>
      <table-wrap id="TB1" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Statistics for the important fields included in MIRKB</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Data content</th>
              <th align="center" rowspan="1" colspan="1">Number of entries</th>
              <th align="center" rowspan="1" colspan="1">Number of categories</th>
              <th align="center" rowspan="1" colspan="1">Data content</th>
              <th align="center" rowspan="1" colspan="1">Number of entries</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" colspan="3" rowspan="1">
                <bold>Classification</bold>
              </td>
              <td align="left" colspan="2" rowspan="1">
                <bold>Population</bold>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Single factor</td>
              <td align="center" rowspan="1" colspan="1">7902</td>
              <td align="center" rowspan="1" colspan="1">1847</td>
              <td align="left" rowspan="1" colspan="1">Young</td>
              <td align="center" rowspan="1" colspan="1">572</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Molecular factor</td>
              <td align="center" rowspan="1" colspan="1">2356</td>
              <td align="center" rowspan="1" colspan="1">649</td>
              <td align="left" rowspan="1" colspan="1">Elderly</td>
              <td align="center" rowspan="1" colspan="1">217</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Protein</td>
              <td align="center" rowspan="1" colspan="1">1274</td>
              <td align="center" rowspan="1" colspan="1">277</td>
              <td align="left" colspan="2" rowspan="1">
                <bold>Application</bold>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> DNA</td>
              <td align="center" rowspan="1" colspan="1">423</td>
              <td align="center" rowspan="1" colspan="1">162</td>
              <td align="left" rowspan="1" colspan="1">Risk assessment</td>
              <td align="center" rowspan="1" colspan="1">1755</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> RNA</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">56</td>
              <td align="left" rowspan="1" colspan="1">Diagnosis</td>
              <td align="center" rowspan="1" colspan="1">279</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Other</td>
              <td align="center" rowspan="1" colspan="1">577</td>
              <td align="center" rowspan="1" colspan="1">154</td>
              <td align="left" rowspan="1" colspan="1">Prognosis</td>
              <td align="center" rowspan="1" colspan="1">6163</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Imaging</td>
              <td align="center" rowspan="1" colspan="1">821</td>
              <td align="center" rowspan="1" colspan="1">252</td>
              <td align="left" rowspan="1" colspan="1">Treatment</td>
              <td align="center" rowspan="1" colspan="1">112</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Physiological factor</td>
              <td align="center" rowspan="1" colspan="1">1566</td>
              <td align="center" rowspan="1" colspan="1">219</td>
              <td align="left" rowspan="1" colspan="1">Other</td>
              <td align="center" rowspan="1" colspan="1">127</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Clinical factor</td>
              <td align="center" rowspan="1" colspan="1">2523</td>
              <td align="center" rowspan="1" colspan="1">561</td>
              <td align="left" colspan="2" rowspan="1">
                <bold>MI type</bold>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Disease history</td>
              <td align="center" rowspan="1" colspan="1">1780</td>
              <td align="center" rowspan="1" colspan="1">370</td>
              <td align="left" rowspan="1" colspan="1">Disease phase</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Family history</td>
              <td align="center" rowspan="1" colspan="1">39</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1"> Acute</td>
              <td align="center" rowspan="1" colspan="1">6282</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Treatment history</td>
              <td align="center" rowspan="1" colspan="1">520</td>
              <td align="center" rowspan="1" colspan="1">134</td>
              <td align="left" rowspan="1" colspan="1"> Old</td>
              <td align="center" rowspan="1" colspan="1">154</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Other</td>
              <td align="center" rowspan="1" colspan="1">184</td>
              <td align="center" rowspan="1" colspan="1">52</td>
              <td align="left" rowspan="1" colspan="1">Lesion range</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Environmental factor</td>
              <td align="center" rowspan="1" colspan="1">46</td>
              <td align="center" rowspan="1" colspan="1">26</td>
              <td align="left" rowspan="1" colspan="1"> Transmural</td>
              <td align="center" rowspan="1" colspan="1">30</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Lifestyle factor</td>
              <td align="center" rowspan="1" colspan="1">306</td>
              <td align="center" rowspan="1" colspan="1">65</td>
              <td align="left" rowspan="1" colspan="1"> Subendocardial</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Behavioral hobby</td>
              <td align="center" rowspan="1" colspan="1">163</td>
              <td align="center" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">Infarction location</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Eating habit</td>
              <td align="center" rowspan="1" colspan="1">104</td>
              <td align="center" rowspan="1" colspan="1">46</td>
              <td align="left" rowspan="1" colspan="1"> Anterior</td>
              <td align="center" rowspan="1" colspan="1">326</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Exercise habit</td>
              <td align="center" rowspan="1" colspan="1">34</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1"> Inferior</td>
              <td align="center" rowspan="1" colspan="1">73</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> Routine</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1"> Other sites</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Psychosocial factor</td>
              <td align="center" rowspan="1" colspan="1">284</td>
              <td align="center" rowspan="1" colspan="1">75</td>
              <td align="left" rowspan="1" colspan="1">ECG expression</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Combined factors</td>
              <td align="center" rowspan="1" colspan="1">195</td>
              <td align="center" rowspan="1" colspan="1">157</td>
              <td align="left" rowspan="1" colspan="1"> ST-segment elevation</td>
              <td align="center" rowspan="1" colspan="1">2859</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Risk model</td>
              <td align="center" rowspan="1" colspan="1">339</td>
              <td align="center" rowspan="1" colspan="1">174</td>
              <td align="left" rowspan="1" colspan="1"> Non-ST-segment elevation</td>
              <td align="center" rowspan="1" colspan="1">195</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" colspan="2" rowspan="1">
                <bold>Clinical type</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Type I</td>
              <td align="center" rowspan="1" colspan="1">8</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Type II</td>
              <td align="center" rowspan="1" colspan="1">6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Type III</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Type IV</td>
              <td align="center" rowspan="1" colspan="1">27</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Type V</td>
              <td align="center" rowspan="1" colspan="1">18</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>By analyzing the entries in the MIRKB, it indicates that the related works keep increasing year by year (<xref rid="f2" ref-type="fig">Figure 2a</xref>), suggesting that research on MI remains one of the hottest topics in the field of complex cardiovascular diseases all the time. Following this tendency, it is foreseeable that more studies related to MI will be published for the risk assessment, diagnosis, prognosis and treatment of MI, and we will integrate them into MIRKB. The MIRKB has collected the studies related to MI from 83 countries in 6 continents. The country with the largest number of studies is USA, followed by China and others (<xref rid="f2" ref-type="fig">Figure 2b</xref>). The continent with the largest number of studies is Europe, followed by Asia and North America (<xref rid="f2" ref-type="fig">Figure 2c</xref>). The risk factors and models are mostly for prognosis in terms of their clinical application distribution, followed by risk assessment and diagnosis (<xref rid="f2" ref-type="fig">Figure 2d–f</xref>).</p>
      <fig id="f2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Examples of statistical analyses from the MIRKB.</bold> (<bold>A</bold>) Study number distribution according to year of publication; (<bold>B</bold> and <bold>C</bold>) study number distribution according to research region; (<bold>D–F</bold>) showed number distribution of single factors, combined factors and risk models according to their application, respectively.</p>
        </caption>
        <graphic xlink:href="baz125f2"/>
      </fig>
    </sec>
    <sec id="sec4">
      <title>Database architecture</title>
      <p>MIRKB is a relational database, and it includes information regarding risk factors, models, MI, references, samples and the relationships between them. The entity relationships of the MIRKA are depicted in <xref rid="f3" ref-type="fig">Figure 3</xref>. The conceptual architecture described was designed to facilitate the inclusion of new factors related to MI when updating the database.</p>
      <fig id="f3" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Entity relationship diagram of MIRKB.</p>
        </caption>
        <graphic xlink:href="baz125f3"/>
      </fig>
    </sec>
    <sec id="sec5">
      <title>Database implementation details</title>
      <p>The MIRKB applied PHP (<ext-link ext-link-type="uri" xlink:href="http://www.php.net/">http://www.php.net/</ext-link>) development technology with MySQL (<ext-link ext-link-type="uri" xlink:href="http://www.mysql.com">http://www.mysql.com</ext-link>) as the background database running on an Apache server, where HTML and CSS scripting languages were employed for client side coding, and the Web platform is based on the Browser/Server (B/S) mode.</p>
    </sec>
    <sec id="sec6">
      <title>Web framework</title>
      <p>The web framework of the MIRKB has six components: (i) the ‘Home’ page for providing brief introduction of MIRKB, (ii) the ‘Search’ page provides navigation bar search, keywords search, and advanced search for browsing and retrieving data, (iii) the ‘MI introduction’ page provides the definition of different MI types and external links (Wikipedia and PubMed website), (iv) the ’Submission’ page for users to submit new data related to MI, (v) the ‘Download’ page for users to download all the data of MIRKB and (vi) the ‘Help’ page for users to make full use of MIRKB (<xref rid="f4" ref-type="fig">Figure 4a</xref>).</p>
      <fig id="f4" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>MIRKB interface.</bold> (<bold>A</bold>) ‘Search’ page. (<bold>B</bold>) ‘Detailed search results’ interface. (<bold>C</bold>) Example of ‘Advanced search’. (<bold>D</bold>) ‘MI introduction’ page.</p>
        </caption>
        <graphic xlink:href="baz125f4"/>
      </fig>
    </sec>
    <sec id="sec7">
      <title>Navigation bar and keywords search</title>
      <p>The ‘Search’ page comprises a search box, navigation bar and results list (<xref rid="f4" ref-type="fig">Figure 4a</xref>). A simple text search and a navigation bar are provided for fast data retrieval based on a single keyword. The database can be searched using the risk factor name, objective, region and reference (including the first author’s name, published journal and year of research), and it may be browsed by risk factor classification, research population and MI type. The screenshot in <xref rid="f4" ref-type="fig">Figure 4a</xref> shows an example of a keyword search, where we searched records related to smoking and 172 entries were retrieved. Clicking on the results list allowed us to enter the ‘Detailed search results’ interface (<xref rid="f4" ref-type="fig">Figure 4b</xref>). The results table includes data such as risk factor information (name, classification, subclassification and description), MI type, information about published references (PubMed ID, first author’s name, journal and year of research), sample information (population, sample number, sample gender, region, race, disease history, treatment history, source and method), application, objective, statistics and conclusion of the research. The table also provides PubMed link of the related studies.</p>
    </sec>
    <sec id="sec8">
      <title>Advanced search</title>
      <p>The ‘Advanced’ button can be clicked to make the ‘Advanced search’ (<xref rid="f4" ref-type="fig">Figure 4a</xref>). The advanced search is a more powerful method for querying a database. Users can combine and specify different search terms to obtain more accurate results. The screenshot in <xref rid="f4" ref-type="fig">Figure 4c</xref> shows an example of the advanced search, where we searched details of the relationship between the combination of smoking and age, and the prognosis of acute MI, and one record was retrieved.</p>
    </sec>
    <sec id="sec9">
      <title>Statistical tool</title>
      <p>MIRKB also provides a web tool for data statistics. If you want to use this tool, you need to click ‘Tool’ link(<xref rid="f4" ref-type="fig">Figure 4a</xref>), and then the web page will jump into the ‘Tool’ page (<xref rid="f4" ref-type="fig">Figure 4d</xref>). First and foremost, you need to choose a type of MI. And then, choose the research population and the application of the risk factors which you want to know. Finally, choose one of the buttons to draw the chart you want. This tool provides two charts including a network diagram and a pie chart. In this example, based on these two graphs, we can see that among the young population, molecular factors are the most in the risk factors related to the risk assessment of acute MI.</p>
    </sec>
    <sec id="sec10">
      <title>MI introduction page</title>
      <p>The ‘MI introduction’ page has a navigation bar and an information box. A detailed introduction to MI can be accessed by clicking on the left navigation bar to enter Wikipedia, including details of the terminology, signs and symptoms, causes, mechanism and diagnosis of MI. MI has different classification methods according to the disease phase, lesion range, infarction location, ECG expression and clinical type. According to the disease phase, MI can be divided into acute and old MI. MI can be categorized as transmural and subendocardial MI based on the lesion range of the infarction. According to the ECG expression, MI can be differentiated into silent, ST-segment elevation, non-ST-segment elevation, Q wave and non-Q wave MI. MI can be classified as anterior, inferior and MI of other sites according to the location. MI can be classified as type I, type II, type III, type IV (type IV includes type IVa and IVb) and type V MI according to the clinical type. The information box on the right-hand side provides access to the detail of the MI types.</p>
      <table-wrap id="TB2" orientation="portrait" position="float">
        <label>Table 2</label>
        <caption>
          <p>Comparisons of other biomedical databases</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="left" rowspan="1" colspan="1">CBD</th>
              <th align="left" rowspan="1" colspan="1">AGD</th>
              <th align="left" rowspan="1" colspan="1">GIDB</th>
              <th align="left" rowspan="1" colspan="1">MIRKB</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Purpose of the database</td>
              <td align="left" rowspan="1" colspan="1">A database for collecting biomarkers related to the diagnosis, treatment or prognosis of colorectal cancer from the literature</td>
              <td align="left" rowspan="1" colspan="1">A database for collecting genes associated with aneurysm in human, rat and mouse from both the literature and data available in public databases</td>
              <td align="left" rowspan="1" colspan="1">A database for collecting genes associated with gastrointestinal cancer from both the literature and data available in public databases</td>
              <td align="left" rowspan="1" colspan="1">A database for collecting risk factors and risk models related to the diagnosis, treatment or prognosis of MI from literature</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Data resource</td>
              <td align="left" rowspan="1" colspan="1">Scientific literature</td>
              <td align="left" rowspan="1" colspan="1">Scientific literature and other scientific resources</td>
              <td align="left" rowspan="1" colspan="1">Scientific literature and other scientific resources</td>
              <td align="left" rowspan="1" colspan="1">Scientific literature</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Data collection</td>
              <td align="left" rowspan="1" colspan="1">Manually curated</td>
              <td align="left" rowspan="1" colspan="1">Manually curated</td>
              <td align="left" rowspan="1" colspan="1">Automated text mining</td>
              <td align="left" rowspan="1" colspan="1">Manually curated</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Analysis function</td>
              <td align="left" rowspan="1" colspan="1">No</td>
              <td align="left" rowspan="1" colspan="1">No</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="sec11">
      <title>Submission page</title>
      <p>Another important feature implemented in MIRKB allows collaborative extension of the knowledge base. Currently, MIRKB contains relevant information from PubMed before 5 July 2019. However, MIRKB is not real-time updated and related data may not be updated in time, thus we implemented a submission function to allow users to help us to improve the MIRKB. Users can contribute to the project by submitting new MI data, which can be uploaded via the online submission form and added to the database after careful review.</p>
    </sec>
    <sec id="sec12">
      <title>Download page</title>
      <p>The ‘Download’ page lists all the data in MIRKB that is available for downloading.</p>
    </sec>
    <sec id="sec13">
      <title>Comparisons with other databases</title>
      <p>We compared our MIRKB with other related biomedical databases, such as colorectal cancer (CRC) biomarker database (CBD) (<xref rid="ref32" ref-type="bibr">32)</xref>, aneurysm gene database (AGD) (<xref rid="ref33" ref-type="bibr">33)</xref> and gastrointestinal (GI) cancer knowledge database (GIDB) (<xref rid="ref34" ref-type="bibr">34)</xref> listed in <xref rid="TB2" ref-type="table">Table 2</xref>. The advantages of MIRKB are as follows: (i) the use of manual text-mining to make data in MIRKB more accurate, compared with automatic text-mining based databases, (ii) provide a statistical tool for the analysis between MI and risk factors and (iii) the data collection range is wide, including molecular factors, imaging, physiological factors, clinical factors, environmental factors, lifestyle factors and psychosocial factors, and combine factors as well as risk models. The MIRKB also provides users with very friendly interfaces and interactive tools, by which users can get the information they are interested in by browsing, keyword search or advanced search. At present, MIRKB only includes data extracted from PubMed, not EMBASE, EBSCO, Web of Science, OVID, etc., which may result in some valuable data not being entered into the database. Taken together, the MIRKB is an integrated research platform for studying the interactions of factors, risk models and MI, which is a unique and will be helpful to the future modeling and understanding of MI.</p>
    </sec>
  </sec>
  <sec id="sec14">
    <title>Conclusion and discussion</title>
    <p>MI is a common disease that poses a serious threat to human health. After an MI, lots of cardiomyocytes are necrotic, gradually replaced by fibrous tissue, resulting left ventricular remodeling, which eventually leads to congestive heart failure (<xref rid="ref35" ref-type="bibr">35)</xref>. With the rapid development of modern medicine, more and more methods are available for the treatment of MI, such as coronary intervention, bypass surgery, drugs, etc. Myocardial necrosis is an irreversible process and these treatments can prevent the procession of remodeling to a certain extent, but cannot repair or reverse the necrotic myocardium, let alone promote myocardial regeneration (<xref rid="ref36" ref-type="bibr">36)</xref>. Therefore, the early prevention, detection, diagnosis and treatment of MI are imperative. A growing number of risk factors have been shown to be associated with the development, progression, treatment and prognosis of MI, and different types of MI could have different risk factors. It is still a challenge to identify the precision risk factors for different types of MI for the early diagnosis, treatment and prognosis of the disease. With the accumulation of MI studies the systems biological level understanding of MI is becoming reality also necessary. The deep phenotyping based on combination of trans-omics factors will facilitate the precision and personalized diagnosis, prognosis and treatment of MI.</p>
    <p>We created MIRKB to provide more comprehensive and accurate information to facilitate MI research at systems level. With MIRKB, researchers may obtain specific knowledge for risk factors, protective factors or biomarkers of typical MI types. Users can search for combined factors or risk models to predict the diagnosis, prognosis or treatment of MI. MIRKB contains 7902 entries for 1847 single factors, 195 entries for 157 combined factors and 339 entries for 174 risk models. The single factor types comprise molecular factor (2356 entries, 649 factors), imaging (821 entries, 252 factors), physiological factor (1566 entries, 219 factors), clinical factor (2523 entries, 561 factors), environmental factor (46 entries, 26 factors), lifestyle factor (306 entries, 65 factors) and psychosocial factor (284 entries, 75 factors). Moreover, the database includes five different classification methods of MI, which is more conducive to understanding the risk, development, treatment and prognosis of MI.</p>
    <p>Based on our best knowledge, MIRKB is the first online resource to gather all kinds of risk factors and models for MI. In order to build an integrated research platform for studying the interactions of factors, risk models and MI, continued efforts will be made to update the MI data, and to improve the data’s diversity and quality. We will keep the updating of MIRKB and improve and refine the database functionality, and try to build systems level and personalized models for the precision prediction of MI.</p>
  </sec>
</body>
<back>
  <sec id="sec15">
    <title>Funding</title>
    <p>National Natural Science Foundation of China (31670851); National Key Research and Development Program of China (2016YFC1306605).</p>
    <p><italic>Conflict of interest</italic>. None declared.</p>
  </sec>
  <notes id="AN1">
    <p><bold>Database URL</bold>: <ext-link ext-link-type="uri" xlink:href="http://sysbio.org.cn/MIRKB/">http://sysbio.org.cn/MIRKB/</ext-link></p>
  </notes>
  <ref-list id="bib1">
    <title>References</title>
    <ref id="ref1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benjamin</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Muntner</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Heart disease and stroke statistics-2019 update: a report from the American Heart Association</article-title>. <source>Circulation</source>, <volume>139</volume>, <fpage>e58</fpage>–<lpage>e528</lpage>.</mixed-citation>
    </ref>
    <ref id="ref2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bawaskar</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Bawaskar</surname><given-names>P.H.</given-names></name> and <name name-style="western"><surname>Bawaskar</surname><given-names>P.H.</given-names></name></person-group> (<year>2019</year>) <article-title>Preintensive care: thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital</article-title>. <source>J Family Med Prim Care</source>, <volume>8</volume>, <fpage>62</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">30911482</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chien</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C.H.</given-names></name>, <name name-style="western"><surname>Chao</surname><given-names>Z.H.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Different treatments for acute myocardial infarction patients via outpatient clinics and emergency department</article-title>. <source>Medicine</source>, <volume>e13883</volume>, <fpage>98</fpage>.</mixed-citation>
    </ref>
    <ref id="ref4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>The effects of atorvastatin on interventional therapy in patients with acute myocardial infarction</article-title>. <source>Minerva Med.</source>, <volume>110</volume>, <fpage>101</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="pmid">29696937</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forcadell</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Vila-Corcoles</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>de Diego</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Incidence and mortality of myocardial infarction among Catalonian older adults with and without underlying risk conditions: the CAPAMIS study</article-title>. <source>Eur. J. Prev. Cardiol.</source>, <volume>25</volume>, <fpage>1822</fpage>–<lpage>1830</lpage>.<pub-id pub-id-type="pmid">30019923</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin Castellanos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Cabanas Armesilla</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Barca Duran</surname><given-names>F.J.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Obesity and risk of myocardial infarction in a sample of European males. Waist to-hip-ratio presents information bias of the real risk of abdominal obesity</article-title>. <source>Nutr. Hosp.</source>, <volume>34</volume>, <fpage>88</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">28244777</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alzahrani</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Pena</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Temesgen</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Association between electronic cigarette use and myocardial infarction</article-title>. <source>Am. J. Prev. Med.</source>, <volume>55</volume>, <fpage>455</fpage>–<lpage>461</lpage>.<pub-id pub-id-type="pmid">30166079</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>La Torre</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Saulle</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Di Murro</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Mediterranean diet adherence and synergy with acute myocardial infarction and its determinants: a multicenter case-control study in Italy</article-title>. <source>PLoS One</source>, <volume>13</volume>, <fpage>e0193360</fpage>.<pub-id pub-id-type="pmid">29543823</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Influence of interleukin-1beta gene polymorphism on the risk of myocardial infarction complicated with ischemic stroke</article-title>. <source>Exp. Ther. Med.</source>, <volume>16</volume>, <fpage>5166</fpage>–<lpage>5170</lpage>.<pub-id pub-id-type="pmid">30542472</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction</article-title>. <source>Lipids Health Dis.</source>, <volume>18</volume>, <fpage>95</fpage>.<pub-id pub-id-type="pmid">30971288</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Attard</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dingli</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Doggen</surname><given-names>C.J.M.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction</article-title>. <source>Open Heart</source>, <volume>4</volume>, <fpage>e000620</fpage>.<pub-id pub-id-type="pmid">28878948</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Redfors</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: analysis from the HORIZONS-AMI trial</article-title>. <source>Catheter. Cardiovasc. Interv.</source>, <volume>94</volume>, <fpage>172</fpage>–<lpage>180</lpage>.<pub-id pub-id-type="pmid">30690854</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Renyi distribution entropy aalysis of short-term heart rate variability signals and its application in coronary artery disease detection</article-title>. <source>Front. Physiol.</source>, <volume>10</volume>, <fpage>809</fpage>.<pub-id pub-id-type="pmid">31293457</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prescott</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Scharling</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Osler</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>) <article-title>Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in the Copenhagen City heart study</article-title>. <source>J. Epidemiol. Community Health</source>, <volume>56</volume>, <fpage>702</fpage>–<lpage>706</lpage>.<pub-id pub-id-type="pmid">12177089</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinstadler</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Eitel</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Fuernau</surname><given-names>G.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction</article-title>. <source>Eur. Heart J. Cardiovasc. Imaging</source>, <volume>18</volume>, <fpage>39</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">26976354</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steele</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Lloyd</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fotheringham</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>A retrospective cohort study of the association between smoking and mortality after acute ST-segment elevation myocardial infarction</article-title>. <source>Postgrad. Med. J.</source>, <volume>93</volume>, <fpage>489</fpage>–<lpage>493</lpage>.<pub-id pub-id-type="pmid">28254999</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ek</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ekblom</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Hambraeus</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Physical inactivity and smoking after myocardial infarction as predictors for readmission and survival: results from the SWEDEHEART-registry</article-title>. <source>Clin. Res. Cardiol.</source>, <volume>108</volume>, <fpage>324</fpage>–<lpage>332</lpage>.<pub-id pub-id-type="pmid">30167806</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubesch</surname><given-names>N.J.</given-names></name>, <name name-style="western"><surname>Therming Jorgensen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Effects of leisure-time and transport-related physical activities on the risk of incident and recurrent myocardial infarction and interaction with traffic-related air pollution: a cohort study</article-title>. <source>J. Am. Heart Assoc.</source>, <volume>7</volume>, <comment>e009554</comment>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gehani</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Al-Hinai</surname><given-names>A.T.</given-names></name>, <name name-style="western"><surname>Zubaid</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>) <article-title>Association of risk factors with acute myocardial infarction in middle eastern countries: the INTERHEART Middle East study</article-title>. <source>Eur. J. Prev. Cardiol.</source>, <volume>21</volume>, <fpage>400</fpage>–<lpage>410</lpage>.<pub-id pub-id-type="pmid">23125402</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vavik</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>E.K.R.</given-names></name>, <name name-style="western"><surname>Svingen</surname><given-names>G.F.T.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Usefulness of higher levels of cardiac troponin T in patients with stable angina pectoris to predict risk of acute myocardial infarction</article-title>. <source>Am. J. Cardiol.</source>, <volume>122</volume>, <fpage>1142</fpage>–<lpage>1147</lpage>.<pub-id pub-id-type="pmid">30146101</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jedrychowska</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Januszek</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Plens</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Impact of sex on the follow-up course and predictors of clinical outcomes in patients hospitalised due to myocardial infarction with non-obstructive coronary arteries: a single-Centre experience</article-title>. <source>Kardiol. Pol.</source>, <volume>77</volume>, <fpage>198</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="pmid">30604859</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>French</surname><given-names>J.K.</given-names></name>, <name name-style="western"><surname>Ramanathan</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>J.T.</given-names></name><etal>et al.</etal></person-group> (<year>2003</year>) <article-title>A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction</article-title>. <source>Am. Heart J.</source>, <volume>145</volume>, <fpage>508</fpage>–<lpage>514</lpage>.<pub-id pub-id-type="pmid">12660675</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hueb</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Gersh</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Alves da Costa</surname><given-names>L.M.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>Accuracy of myocardial biomarkers in the diagnosis of myocardial infarction after revascularization as assessed by cardiac resonance: the medicine, angioplasty, surgery study V (MASS-V) trial</article-title>. <source>Ann. Thorac. Surg.</source>, <volume>101</volume>, <fpage>2202</fpage>–<lpage>2208</lpage>.<pub-id pub-id-type="pmid">26912303</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zbierska-Rubinkiewicz</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Trebacz</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Tomala</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Creatine kinase-MB and red cell distribution width as predictors of contrast-induced nephropathy after percutaneous coronary intervention in acute myocardial infarction</article-title>. <source>Folia Med. Cracov.</source>, <volume>57</volume>, <fpage>87</fpage>–<lpage>99</lpage>.</mixed-citation>
    </ref>
    <ref id="ref25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Attachaipanich</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Krittayaphong</surname><given-names>R.</given-names></name></person-group> (<year>2019</year>) <article-title>Fragmented QRS as a predictor of in-hospital life-threatening arrhythmic complications in ST-elevation myocardial infarction patients</article-title>. <source>Ann Noninvasive Electrocardiol</source>, <volume>24</volume>, <fpage>e12593</fpage>.<pub-id pub-id-type="pmid">30117636</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Huo</surname><given-names>Z.</given-names></name></person-group> (<year>2019</year>) <article-title>Serum circulating miR-150 is a predictor of post-acute myocardial infarction heart failure</article-title>. <source>Int. Heart J.</source>, <volume>60</volume>, <fpage>280</fpage>–<lpage>286</lpage>.<pub-id pub-id-type="pmid">30745540</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaudewitz</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Zampetaki</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Mayr</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>) <article-title>MicroRNA biomarkers for coronary artery disease?</article-title><source>Curr. Atheroscler. Rep.</source>, <volume>17</volume>, <fpage>70</fpage>.<pub-id pub-id-type="pmid">26490079</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: an independent study of Han population</article-title>. <source>Exp. Gerontol.</source>, <volume>72</volume>, <fpage>230</fpage>–<lpage>238</lpage>.<pub-id pub-id-type="pmid">26526403</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>Q.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>) <article-title>Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction</article-title>. <source>Int. J. Biol. Sci.</source>, <volume>8</volume>, <fpage>811</fpage>–<lpage>818</lpage>.<pub-id pub-id-type="pmid">22719221</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>X.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Sensitive miRNA markers for the detection and management of NSTEMI acute myocardial infarction patients</article-title>. <source>J. Thorac. Dis.</source>, <volume>10</volume>, <fpage>3206</fpage>–<lpage>3215</lpage>.<pub-id pub-id-type="pmid">30069316</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cortez-Dias</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Carrilho-Ferreira</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>) <article-title>Circulating miR-122-5p/miR-133b ratio is a specific early prognostic biomarker in acute myocardial infarction</article-title>. <source>Circ. J.</source>, <volume>80</volume>, <fpage>2183</fpage>–<lpage>2191</lpage>.<pub-id pub-id-type="pmid">27593229</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>X.F.</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>CBD: a biomarker database for colorectal cancer</article-title>. <source>Database (Oxford)</source>, <volume>2018</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="ref33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>AGD: aneurysm gene database</article-title>. <source>Database (Oxford)</source>, <volume>2018</volume>, <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
    </ref>
    <ref id="ref34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>GIDB: a knowledge database for the automated curation and multidimensional analysis of molecular signatures in gastrointestinal cancer</article-title>. <source>Database (Oxford)</source>, <volume>2019</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
    </ref>
    <ref id="ref35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whittaker</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Boughner</surname><given-names>D.R.</given-names></name> and <name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name></person-group> (<year>1991</year>) <article-title>Role of collagen in acute myocardial infarct expansion</article-title>. <source>Circulation</source>, <volume>84</volume>, <fpage>2123</fpage>–<lpage>2134</lpage>.<pub-id pub-id-type="pmid">1934383</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Betgem</surname><given-names>R.P.</given-names></name>, <name name-style="western"><surname>de Waard</surname><given-names>G.A.</given-names></name>, <name name-style="western"><surname>Nijveldt</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Intramyocardial haemorrhage after acute myocardial infarction</article-title>. <source>Nat. Rev. Cardiol.</source>, <volume>12</volume>, <fpage>156</fpage>–<lpage>167</lpage>.<pub-id pub-id-type="pmid">25403783</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
